Esposito Pamela is Chief Business Officer of Replimune Group Inc.
Person profile
Roles
Replimune
Chief Business Officer
Kymera Therapeutics
Director
Address
Woburn, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Replimune Group, Inc.
13 Sep 23
4
Replimune Group, Inc.
24 Aug 23
4
Replimune Group, Inc.
15 Aug 23
4
Replimune Group, Inc.
11 Jul 23
144
Replimune Group, Inc.
10 Jul 23
4
Kymera Therapeutics, Inc.
20 Jun 23
4
Replimune Group, Inc.
18 May 23
4
Replimune Group, Inc.
4 Apr 23
4
Replimune Group, Inc.
13 Dec 22
4
Kymera Therapeutics, Inc.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Sep 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20 | 300 | 6.00 k | 263,436 |
12 Sep 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 300 | 990.00 | 263,736 |
12 Sep 23 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.3 | 300 | 990.00 | 86,033 |
11 Sep 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20.01 | 5,358 | 107.21 k | 263,436 |
11 Sep 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 5,358 | 17.68 k | 268,794 |
11 Sep 23 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.3 | 5,358 | 17.68 k | 86,333 |
22 Aug 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20.01 | 18,600 | 372.19 k | 263,436 |
22 Aug 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 15.5 | 5,000 | 77.50 k | 282,036 |
22 Aug 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 13,600 | 44.88 k | 277,036 |
22 Aug 23 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 15.5 | 5,000 | 77.50 k | 35,750 |